Carregant...
Acinetobacter Prosthetic Joint Infection Treated with Debridement and High-Dose Tigecycline
Prosthesis retention is not recommended for multidrug-resistant Acinetobacter prosthetic joint infection due to its high failure rate. Nevertheless, replacing the prosthesis implies high morbidity and prolonged hospitalization. Although tigecycline is not approved for the treatment of prosthetic joi...
Guardat en:
| Publicat a: | Infect Chemother |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5204012/ https://ncbi.nlm.nih.gov/pubmed/27883369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3947/ic.2016.48.4.324 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|